Kanada -
Englisch -
Health Canada
niaspan tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 500mg - nicotinic acid 500mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
niaspan tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 750mg - nicotinic acid 750mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
niaspan tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 1000mg - nicotinic acid 1000mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
niaspan fct tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 500mg - nicotinic acid 500mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
niaspan fct tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 750mg - nicotinic acid 750mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
niaspan fct tablet (extended-release)
sunovion pharmaceuticals canada inc - nicotinic acid - tablet (extended-release) - 1000mg - nicotinic acid 1000mg - miscellaneous antilipemic agents
Kanada -
Englisch -
Health Canada
advicor tablet (immediate release)
sepracor pharmaceuticals inc - nicotinic acid; lovastatin - tablet (immediate release) - 500mg; 20mg - nicotinic acid 500mg; lovastatin 20mg - hmg-coa reductase inhibitors
Kanada -
Englisch -
Health Canada
advicor tablet (immediate release)
sepracor pharmaceuticals inc - nicotinic acid; lovastatin - tablet (immediate release) - 1000mg; 20mg - nicotinic acid 1000mg; lovastatin 20mg - hmg-coa reductase inhibitors
Kanada -
Englisch -
Health Canada
advicor tablet (immediate release)
sepracor pharmaceuticals inc - nicotinic acid; lovastatin - tablet (immediate release) - 1000mg; 40mg - nicotinic acid 1000mg; lovastatin 40mg - hmg-coa reductase inhibitors
Australien -
Englisch -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
nv tridenosen injection
ceva animal health pty ltd - potassium aspartate; magnesium aspartate; nicotinic acid; di-isopropylamine dichloroacetate; sodium selenite; adenosine triphosphate - parenteral liquid/solution/suspension - potassium aspartate amino acid-aspartate active 20.0 mg/ml; magnesium aspartate amino acid-aspartate active 20.0 mg/ml; nicotinic acid alkaloid active 20.0 mg/ml; di-isopropylamine dichloroacetate ungrouped active 50.0 mg/ml; sodium selenite mineral-selenium active 0.5 mg/ml; adenosine triphosphate nucleotide active 2.0 mg/ml - cardiovascular system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - vascular system reactant | cardiac stimulant | coronary vasodilator | navicular disease | reactants on vascular system | respiratory stimulant | tick paralysis | vascular system | vasodilation